Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial
David A. Palma(London Health Sciences Centre), Robert Olson(Positive Living North), Stephen Harrow(Beatson West of Scotland Cancer Centre), Stewart Gaede(London Health Sciences Centre), Alexander V. Louie(London Health Sciences Centre), Cornelis J.A. Haasbeek(Vrije Universiteit Amsterdam), Liam Mulroy(Nova Scotia Cancer Centre), Michael Lock(London Health Sciences Centre), George Rodrigues(London Health Sciences Centre), Brian Yaremko(London Health Sciences Centre), Devin Schellenberg(Surrey Place Centre), Belal Ahmad(London Health Sciences Centre), Gwendolyn H.M.J. Griffioen(Vrije Universiteit Amsterdam), Sashendra Senthi(Alfred Health), Anand Swaminath(Juravinski Cancer Centre), Neil Kopek(McGill University Health Centre), Mitchell Liu, Karen Moore(Beatson West of Scotland Cancer Centre), Suzanne Currie(Beatson West of Scotland Cancer Centre), Glenn Bauman(London Health Sciences Centre), Andrew Warner(London Health Sciences Centre), Suresh Senan(Vrije Universiteit Amsterdam)
Cited by 1,845
Abstract
Related Papers
No related papers found
Powered by citation graph analysis